Export 6 results:
[ Author(Asc)] Title Type Year
Filters: First Letter Of Last Name is I  [Clear All Filters]
A B C D E F G H I J K L M N O P Q R S T U V W X Y Z 
I
Iyer S, Bhatia P, Rao M, Mukherjee O.  2018.  Developing two reference control samples for the Indian population.. Stem Cell Res. 30:38-42. DOI:10.1016/j.scr.2018.05.001.
Ishtiaq F, Renner S.C..  2020.  Bird Migration and Vector-Borne Parasite Transmission. Avian Malaria and Related Parasites in the Tropics. . DOI:https://doi.org/10.1007/978-3-030-51633-8_16.
Illangeswaran RStephen St, Jebanesan DZechariah, Sivakumar KKanimozhi, Vidhyadharan RThalayattu, Rajamani BM, Janet NBeryl, David E, Velayudhan SRamachandr, Mathews V, Balasubramanian P.  2023.  Corrigendum to "Chemotherapeutic drugs elicit stemness and metabolic alteration to mediate acquired drug-resistant phenotype in acute myeloid leukemia cell lines" [Leukemia Res. 128, 107054].. Leuk Res. 130:107329. DOI:10.1016/j.leukres.2023.107329.
Illangeswaran RStephen St, Jebanesan DZechariah, Sivakumar KKanimozhi, Vidhyadharan RThalayattu, Rajamani BM, Janet NBeryl, David E, Velayudhan SRamachandr, Mathews V, Balasubramanian P.  2023.  Chemotherapeutic drugs elicit stemness and metabolic alteration to mediate acquired drug-resistant phenotype in acute myeloid leukemia cell lines.. Leuk Res. 128:107054. DOI:10.1016/j.leukres.2023.107054.
Ikonomou L, Cuende N, Forte M, Grilley BJ, Levine AD, Munsie M, Rasko JEJ, Turner L, Bidkhori HR, Ciccocioppo R, Grignon F, Srivastava A, Weiss DJ, Zettler P, Levine BL.  2023.  International Society for Cell & Gene Therapy Position Paper: Key considerations to support evidence-based cell and gene therapies and oppose marketing of unproven products.. Cytotherapy. 25(9):920-929. DOI:10.1016/j.jcyt.2023.03.002.
Ijee S, Chambayil K, Chaudhury ADutta, Bagchi A, Modak K, Das S, Benjamin ESathya Bam, Rani S, Paul DZechariah, Nath A, Roy D, Palani D, Priyanka S, Ravichandran R, Kumary BK, Sivamani Y, S V, Babu D, Nakamura Y, Thamodaran V et al..  2023.  Efficient deletion of microRNAs using CRISPR/Cas9 with dual guide RNAs.. Front Mol Biosci. 10:1295507. DOI:10.3389/fmolb.2023.1295507.